ChIP assay was performed using a
ChIP Assay Kit (Cell Signaling Technology, US) as described by Huang et al30 (
link). Briefly, chromatin was crosslinked with 1% formaldehyde. Cells were lysed and sonicated with a Sonics Vibra-Cell processor (Sonics & Materials Inc., US). Chromatin was immuno-precipitated using the corresponding target protein antibody. Immuno-precipitated products were collected using Protein G agarose beads. DNA was purified with RNase A and Proteinase K. The PCR products were then electrophoresed on 2% agarose gels stained with GelRed. The following primers for the PD-L1 promoter were used for RT-PCR as recommended by Marzec et al.22 (
link): 5′- CAAGGTGCGTTCAGATGTTG -3′ and 5′- GGCGTTGGACTTTCCTGA- 3′. The ChIP protocol is described in detail in
supplementary information.
Tong L., Li J., Li Q., Wang X., Medikonda R., Zhao T., Li T., Ma H., Yi L., Liu P., Xie Y., Choi J., Yu S., Lin Y., Dong J., Huang Q., Jin X., Lim M, & Yang X. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics, 10(13), 5943-5956.